At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
QDOT MICRO Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acute Performance Evaluation of the QDOT Micro™ Catheter Used With nGEN Generator in Treatment of Patients With Atrial Fibrillation.
In Brief
A clinical study evaluating QDOT MICRO System for Atrial Fibrillation. Completed, enrolled 40 participants across 1 site.
Detailed Summary
This workflow study will further evaluate the acute performance and safety of the QDOT MICRO™ catheter in a clinical setting used in combination with nGEN Generator. Subjects will be followed for 7 days post procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedSep 2020
Enrollment StartOct 2020
Primary CompletionNov 2021
TodayJul 2026
First PostedSep 11, 2020
Enrollment StartOct 2, 2020
Primary CompletionNov 9, 2021
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.8 years ago
Interventions
QDOT MICRO Systemdevice
QDOT Micro Catheter with nGEN Generator